4.7 Article

Human endogenous retroviruses in development and disease

Journal

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
Volume 19, Issue -, Pages 5978-5986

Publisher

ELSEVIER
DOI: 10.1016/j.csbj.2021.10.037

Keywords

Human endogenous retroviruses (HERVs); Embryonic development and pluripotency; Cancer; Aging; Neurodegenerative diseases

Funding

  1. National Natural Science Foundation of China [31730020, 32000512, 31801155]
  2. Hangzhou Science and Technology Bureau [20182014B01]

Ask authors/readers for more resources

HERVs make up about 8% of the human genome, originating from exogenous retroviral infections millions of years ago and inherited by offspring. While most HERVs are nonprotein-coding, they play important roles in human health and disease by encoding proteins, acting as promoters/enhancers, or lncRNAs.
Human endogenous retroviruses (HERVs) represent similar to 8% of human genome, deriving from exogenous retroviral infections of germ line cells occurred millions of years ago and being inherited by the offspring in a Mendelian fashion. Most of HERVs are nonprotein-coding because of the accumulation of mutations, insertions, deletions, and/or truncations. It has been long thought that HERVs were junk DNA. However, it is now known that HERVs are involved in various biological processes through encoding proteins, acting as promoters/enhancers, or lncRNAs to affect human health and disease. In this review, we summarized recent findings about HERVs, with implications in embryonic development, pluripotency, cancer, aging, and neurodegenerative diseases. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available